These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 33627391)
1. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle. Yang F; Pang B; Lai KK; Cheung NN; Dai J; Zhang W; Zhang J; Chan KH; Chen H; Sze KH; Zhang H; Hao Q; Yang D; Yuen KY; Kao RY J Virol; 2021 Apr; 95(9):. PubMed ID: 33627391 [TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses. Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776 [TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein. Huang F; Chen J; Zhang J; Tan L; Lu G; Luo Y; Pan T; Liang J; Li Q; Luo B; Zhang H; Lu G J Cell Mol Med; 2018 Mar; 22(3):1826-1839. PubMed ID: 29193684 [TBL] [Abstract][Full Text] [Related]
6. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses. Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918 [TBL] [Abstract][Full Text] [Related]
8. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629 [TBL] [Abstract][Full Text] [Related]
9. Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection. Saha P; Saha R; Datta Chaudhuri R; Sarkar R; Sarkar M; Koley H; Chawla-Sarkar M Viruses; 2024 Aug; 16(8):. PubMed ID: 39205291 [TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase. Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558 [TBL] [Abstract][Full Text] [Related]
11. A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity. Li YY; Liang GD; Chen ZX; Zhang K; Liang JL; Jiang LR; Yang SZ; Jiang F; Liu SW; Yang J Acta Pharmacol Sin; 2024 Nov; 45(11):2380-2393. PubMed ID: 38987389 [TBL] [Abstract][Full Text] [Related]
12. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro. Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427 [TBL] [Abstract][Full Text] [Related]
14. A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro. Jones JC; Marathe BM; Lerner C; Kreis L; Gasser R; Pascua PN; Najera I; Govorkova EA Antimicrob Agents Chemother; 2016 Sep; 60(9):5504-14. PubMed ID: 27381402 [TBL] [Abstract][Full Text] [Related]
15. Germacrone inhibits early stages of influenza virus infection. Liao Q; Qian Z; Liu R; An L; Chen X Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670 [TBL] [Abstract][Full Text] [Related]
16. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses. Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830 [TBL] [Abstract][Full Text] [Related]
17. Ceramide Suppresses Influenza A Virus Replication Soudani N; Hage-Sleiman R; Karam W; Dbaibo G; Zaraket H J Virol; 2019 Apr; 93(7):. PubMed ID: 30700605 [TBL] [Abstract][Full Text] [Related]
18. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells. Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970 [TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2. Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854 [TBL] [Abstract][Full Text] [Related]
20. TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection. Patil G; Zhao M; Song K; Hao W; Bouchereau D; Wang L; Li S J Virol; 2018 Aug; 92(16):. PubMed ID: 29899090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]